These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27914809)

  • 1. Actein enhances TRAIL effects on suppressing gastric cancer progression by activating p53/Caspase-3 signaling.
    Yang ZC; Ma J
    Biochem Biophys Res Commun; 2018 Mar; 497(4):1177-1183. PubMed ID: 27914809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Betulinic acid promotes TRAIL function on liver cancer progression inhibition through p53/Caspase-3 signaling activation.
    Xu Y; Li J; Li QJ; Feng YL; Pan F
    Biomed Pharmacother; 2017 Apr; 88():349-358. PubMed ID: 28119237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irigenin sensitizes TRAIL-induced apoptosis via enhancing pro-apoptotic molecules in gastric cancer cells.
    Xu Y; Gao CC; Pan ZG; Zhou CW
    Biochem Biophys Res Commun; 2018 Feb; 496(3):998-1005. PubMed ID: 29305260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron oxide magnetic nanoparticles combined with actein suppress non-small-cell lung cancer growth in a p53-dependent manner.
    Wang MS; Chen L; Xiong YQ; Xu J; Wang JP; Meng ZL
    Int J Nanomedicine; 2017; 12():7627-7651. PubMed ID: 29089760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor Effect of Periplocin in TRAIL-Resistant gastric cancer cells via upregulation of death receptor through activating ERK1/2-EGR1 pathway.
    Zhao LM; Li L; Huang Y; Han LJ; Li D; Huo BJ; Dai SL; Xu LY; Zhan Q; Shan BE
    Mol Carcinog; 2019 Jun; 58(6):1033-1045. PubMed ID: 30737960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actein induces apoptosis in leukemia cells through suppressing RhoA/ROCK1 signaling pathway.
    Zhou WD; Wang X; Sun XZ; Hu J; Zhang RR; Hong Z
    Int J Oncol; 2017 Dec; 51(6):1831-1841. PubMed ID: 29039493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S; Almasan A
    Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
    Ng CP; Zisman A; Bonavida B
    Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining TRAIL and liquiritin exerts synergistic effects against human gastric cancer cells and xenograft in nude mice through potentiating apoptosis and ROS generation.
    Xie R; Gao CC; Yang XZ; Wu SN; Wang HG; Zhang JL; Yan W; Ma TH
    Biomed Pharmacother; 2017 Sep; 93():948-960. PubMed ID: 28715876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sanguinarine sensitizes human gastric adenocarcinoma AGS cells to TRAIL-mediated apoptosis via down-regulation of AKT and activation of caspase-3.
    Choi WY; Jin CY; Han MH; Kim GY; Kim ND; Lee WH; Kim SK; Choi YH
    Anticancer Res; 2009 Nov; 29(11):4457-65. PubMed ID: 20032392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms.
    Shankar S; Singh TR; Srivastava RK
    Prostate; 2004 Sep; 61(1):35-49. PubMed ID: 15287092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cetuximab enhances TRAIL-induced gastric cancer cell apoptosis by promoting DISC formation in lipid rafts.
    Xu L; Hu X; Qu X; Hou K; Zheng H; Liu Y
    Biochem Biophys Res Commun; 2013 Sep; 439(2):285-90. PubMed ID: 23973713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.
    Toscano F; Fajoui ZE; Gay F; Lalaoui N; Parmentier B; Chayvialle JA; Scoazec JY; Micheau O; Abello J; Saurin JC
    Oncogene; 2008 Jul; 27(30):4161-71. PubMed ID: 18345033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel enhances tumoricidal potential of TRAIL via inhibition of MAPK in resistant gastric cancer cells.
    Li L; Wen XZ; Bu ZD; Cheng XJ; Xing XF; Wang XH; Zhang LH; Guo T; Du H; Hu Y; Fan B; Ji JF
    Oncol Rep; 2016 May; 35(5):3009-17. PubMed ID: 26986870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial treatment with anacardic acid followed by TRAIL augments induction of apoptosis in TRAIL resistant cancer cells by the regulation of p53, MAPK and NFκβ pathways.
    Harsha Raj M; Yashaswini B; Rössler J; Salimath BP
    Apoptosis; 2016 May; 21(5):578-93. PubMed ID: 26921178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R; Bedi A
    Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutlin-3 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulation of death receptor 5 (DR5) in human sarcoma HOS cells and human colon cancer HCT116 cells.
    Hori T; Kondo T; Kanamori M; Tabuchi Y; Ogawa R; Zhao QL; Ahmed K; Yasuda T; Seki S; Suzuki K; Kimura T
    Cancer Lett; 2010 Jan; 287(1):98-108. PubMed ID: 19577358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo.
    Shankar S; Chen X; Srivastava RK
    Prostate; 2005 Feb; 62(2):165-86. PubMed ID: 15389801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cisplatin enhances TRAIL-induced apoptosis in gastric cancer cells through clustering death receptor 4 into lipid rafts].
    Xu L; Qu XJ; Liu YP; Liu J; Zhang Y; Hou KZ; Jiang YH
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):484-8. PubMed ID: 22093622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.